CTI Selects Transperfect's Trial Interactive Platform As New eTMF & Study Start-Up Solution

We're happy to announce our partnership with TransPerfect and our expanded offerings of a new eTMF platform and Study Start-Up solutions.

80% of CTI Studies Meet or Exceed Enrollment Expectations

Most clinical trials fail to meet enrollment timelines, with more than 3/4 of trials delayed beyond initial projections. At CTI approximately 80% of our studies meet or exceed enrollment expectations, despite the challenging patient populations we work in, including rare diseases and gene therapy trials.

3 out of 4 Sites around the World Prefer CTI to Other CROs

CTI announced the results of the independently commissioned site survey that was sent out earlier this year. Overall, three out of four sites prefer CTI over all other CROs, and nearly 95% of respondents view CTI as equal to or better than other CROs that they have recently worked with.

 

Regenerative Medicine / Gene Therapy

Find out how CTI can provide value to regenerative medicine and gene therapy programs as a leader in the field.

Learn More

Transplantation

CTI is a leader in this field with contributions to nearly all transplant-related therapies on the market today.

Learn More

Pediatric / Neonate Populations

The CTI team has diverse experience in pediatric and neonate populations in both clinical study management and regulatory consulting across a wide array of indications.

Learn More

Participate in a Trial

Icon Careers Small Retina

CTI CRC is looking for volunteers to participate in our current trials. 

Learn More

CTI Cares

CTI Cares Heart Icon Transparent

CTI Cares is a way for our employees to raise awareness and financial contributions for the causes they personally feel passionate about.

Learn More